home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Cell-Type Crucial In Asthma Identified

 
  July, 2 2002 1:32
your information resource in human molecular genetics
 
     
Asthma is a disease in which inflammation of hyper-responsive airways and excessive mucus production combine to make breathing extremely difficult, and airflow can become so restricted as to be fatal. The condition is on the increase worldwide.

On a molecular level, asthma is caused by chemicals called cytokines that are produced by Th-2 lymphocyte cells of the immune system. Of these cytokines, interleukin-13 (IL-13) plays a powerful role in the triggering the symptoms of asthma. Now (Nature Medicine), scientists at the University of California, San Francisco have identified the key cells that mediate the effects of IL-13 which give rise to the characteristics of asthma.

Another molecule that plays a key role in the IL-13-asthma pathway is STAT-6 (signal transducers and activators of transcription 6). STAT-6 is a transcription factor, and as such enables the production of RNA from DNA.

David Erle and colleagues created transgenic mice that contained STAT-6 only in cells of the lung lining or epithelium. They found that IL-13 did not cause hyper responsiveness of airways in mice lacking STAT-6, and furthermore, only when STAT-6 was present in the epithelial cells of the lung, did mice show IL-13-hyper-responsiveness and mucus production.

Thus, Erle’s team has identified the cell type and the cytokine that are key to asthma. They write, “The airway epithelium and its cell-surface IL-13 receptors are readily accessible to inhaled drugs…blocking these receptors… could provide one strategy to improve the specificity of asthma treatment.”

Author contact:
Dr David Erle
Department of Medicine
Lung Biology Center
University of California
San Francisco, CA, USA
Tel: +1 415 206 5905
E-mail: erle@itsa.ucsf.edu

Article available online.

(C) Nature Medicine press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2016 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.